Axsome Therapeutics, Inc. (AXSM)
184.30
+1.08
(+0.59%)
USD |
NASDAQ |
Feb 10, 16:00
182.30
-2.00
(-1.09%)
After-Hours: 07:30
Axsome Therapeutics Market Cap : 9.291B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 4.310B |
| Gilead Sciences, Inc. | 182.67B |
| Vanda Pharmaceuticals, Inc. | 438.50M |
| ACADIA Pharmaceuticals, Inc. | 3.840B |
| Amicus Therapeutics, Inc. | 4.412B |
Market Cap Related Metrics
| PS Ratio | 16.16 |
| Price to Book Value | 126.02 |
| Price | 184.30 |
| Earnings Yield | -2.54% |